Oncotarget · 2015 · 79 citations · 33 references
MedicineCell BiologyOncologyCellular MetabolismMitochondrial BiologyMolecular OncologyCancer MetabolismCancer Stem CellsMetabolic ReprogrammingMetabolic Reprogramming In CancerMitochondrial MetabolismProstate CancerGlycolysisImmortalization Of Cancer CellsMetabolic Alterations In CancerOxidative Phosphorylation UncouplingProstate MetabolismStemness RegulationTumor Cell MetabolismTumor Metabolism
// Yali Zhong 1, 2, 3, 4 , Xiaoran Li 3, 4 , Dandan Yu 1 , Xiaoli Li 1 , Yaqing Li 1 , Yuan Long 5 , Yuan Yuan 6 , Zhenyu Ji 7 , Mingzhi Zhang 1 , Jian-Guo Wen 8 , Jahn M. Nesland 3, 4 , Zhenhe Suo 1, 3, 4 1 Department of Oncology, The First Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China 2 Department of Gastroenterology, The Second Affiliated Hospital of Zhengzhou University, Zhengzhou, Henan Province, China 3 Department of Pathology, The Norwegian Radium Hospital, Oslo University Hospital, University of Oslo, Montebello, Oslo, Norway 4 Department of Pathology, Institute for Clinical Medicine, Faculty of Medicine, University of Oslo, Oslo, Norway 5 Department of Surgery, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, Henan Province, China 6 Department of Pathology, Capital Medical University, Beijing, China 7 Department of Oncology, Henan Academy of Medical and Pharmaceutical Sciences, Zhengzhou University, Zhengzhou, Henan Province, China 8 Department of Urology Surgery, The First Affiliated Hospital of Zhengzhou University, Zhengzhou University, Henan, China Correspondence to: Zhenhe Suo, e-mail: zhenhes@medisin.uio.no Keywords: MPC blocker, mitochondrial dysfunction, glycolysis, stemness Received: July 09, 2015 Accepted: September 14, 2015 Published: September 25, 2015 ABSTRACT Aerobic glycolysis is one of the important hallmarks of cancer cells and eukaryotic cells. In this study, we have investigated the relationship between blocking mitochondrial pyruvate carrier (MPC) with UK5099 and the metabolic alteration as well as stemness phenotype of prostatic cancer cells. It was found that blocking pyruvate transportation into mitochondrial attenuated mitochondrial oxidative phosphorylation (OXPHOS) and increased glycolysis. The UK5099 treated cells showed significantly higher proportion of side population (SP) fraction and expressed higher levels of stemness markers Oct3/4 and Nanog. Chemosensitivity examinations revealed that the UK5099 treated cells became more resistant to chemotherapy compared to the non-treated cells. These results demonstrate probably an intimate connection between metabolic reprogram and stem-like phenotype of LnCap cells in vitro . We propose that MPC blocker (UK5099) application may be an ideal model for Warburg effect studies, since it attenuates mitochondrial OXPHOS and increases aerobic glycolysis, a phenomenon typically reflected in the Warburg effect. We conclude that impaired mitochondrial OXPHOS and upregulated glycolysis are related with stem-like phenotype shift in prostatic cancer cells.
33
Otto Warbürg · Science · 1956 · 13.3K citations
Prospective Identification of Tumorigenic Prostate Cancer Stem Cells
Anne T. Collins, Paul A. Berry, Catherine Hyde et al. · Cancer Research · 2005 · 2.8K citations
Medicine, Cell Biology, Oncology +17
A restricted cell population propagates glioblastoma growth after chemotherapy
Jian Chen, Yanjiao Li, Tzong‐Shiue Yu et al. · Nature · 2012 · 2.3K citations
Medicine, Cancer Biology, Oncology +14